Merofic-O 200mg Tablet contains Faropenem, a broad-spectrum oral carbapenem antibiotic effective against a wide range of Gram-positive and Gram-negative bacterial infections. It is primarily indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections caused by susceptible organisms. Faropenem exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The 200mg dosage provides an optimal therapeutic concentration to combat resistant strains while maintaining a favorable safety profile. Merofic-O is well absorbed orally, with good bioavailability and a relatively short half-life, allowing for convenient dosing schedules. It is generally well tolerated, with adverse effects being mild and infrequent, including gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Caution is advised in patients with a history of hypersensitivity to beta-lactam antibiotics. Renal function should be monitored in patients with impaired kidney function to adjust dosing appropriately. Merofic-O 200mg Tablet should be used under medical supervision, with therapy guided by susceptibility testing where possible to prevent the development of resistance. It is contraindicated in viral infections and should not be used indiscriminately to preserve its efficacy.